Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk overview
- Basic concepts
- Functions associated with the basal ganglia
- Parkinson’s disease (PD)
- Sites of neurodegeneration in PD
- The classical model of basal ganglia
- The basal ganglia model in PD
- Key role of dopamine (DA) in the basal ganglia
- The physiological role of DA in the striatum
- DA and glutamate signals in motor learning
- Brain's traffic lights
- Corticostriatal rat brain slices
- Corticostriatal synaptic plasticity
- Effect of DA denervation on synaptic plasticity
- D1 antagonist prevents induction of striatal LTP
- DA regulates corticostriatal synaptic plasticity
- Role of endocannabinoids in striatal LTD
- Is striatal synaptic plasticity induced in vivo?
- A cellular mechanism of reward-related learning
- Synaptic plasticity: "segregated" or "parallel"?
- LTD in neurons of direct & indirect pathways (1)
- LTD in neurons of direct & indirect pathways (2)
- D2 receptor antagonism prevent striatal LTD
- “Late” versus “early” phases of PD
- Model of early PD
- LTD is not altered in a model of early stage PD
- LTP is reduced in a model of early stage PD
- NMDA receptor subunit (NR2A) in early stage PD
- Genetic factors implicated in PD
- Genetic causes of PD
- Inactivation of the DJ-1 gene
- Alpha-synuclein and the dopaminergic synapse
- A53T-SNCA mutation
- DA and other receptors: A2A adenosine and Ach
- Adenosine A(2A) receptors
- Cannabinoids on D2 and A(2A) receptors
- DA with other receptors in PD models
- Interactions in cholinergic interneurons
- Model of cholinergic interneuron & striatal neuron
- Dopamine/ACh interaction in hippocampal LTP
- Striatal DA/ACh interactions in memory storage
- Convergent model
- L-DOPA-induced dyskinesia
- Phenomenology of dyskinesias in PD
- L-DOPA-treated PD rats (1)
- L-DOPA-treated PD rats (2)
- High levels of p-DARPP-32 in dyskinetic rats
- Redistribution of NR2B in dyskinetic rats
- Targeting NR2A reduces dyskinesia
- Model of L-DOPA-induced dyskinesia
- Synaptic plasticity in PD patients
- DA & cortical plasticity in the motor cortex
- Aberrant synaptic plasticity may play a role in PD
- Abnormal depotentiation in motor cortex
- Conclusions
- Acknowledgements
Topics Covered
- Basal ganglia circuits
- Synaptic Plasticity and Striatal Neurotransmitters
- Synaptic Plasticity and NMDA Receptors
- Dopamine and Parkinson’s Disease
- Dopamine Receptors and Striatal Neurons
- Parkinson’s Disease and Levodopa-induced Dyskinesia
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Calabresi, P. (2014, June 2). Synaptic plasticity in striatal function [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/TXDF8049.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Paolo Calabresi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
The topic of this
lecture will be the role
of synaptic plasticity
in striatal function.
This topic is of great importance
both for the physiology
of basal ganglia as well
as for the understanding
of the pathophysiology
of movement disorders
such as Parkinson's disease.
0:23
This presentation will
summarize some critical aspects
of striatal synaptic plasticity in
both physiological and autological
conditions.
We will present data dealing
with the role of dopamine
in basil ganglia and
Parkinson's disease.
We will discuss how synaptic
plasticity plays a key role
in the regulation of physiological
activity of the striatum
and in pathogenetic conditions
such as Parkinson's disease,
and we will also discuss the
interaction between dopamine
and other neurotransmitter
systems in
both physiological and
pathological condition.
Finally, we will show a few
experiments in which the role
of synaptic plasticity
will also be presented
from clinical data in
Parkinson's disease patients.
1:23
The first aspect presented
here will be the critical role
of basal ganglia and dopamine
in motor and nonmotor functions
involving selection processes.
1:38
The complex circuitry
of the basal ganglia
and the dopaminergic
transmission are
involved in a wide
range of functions.
They have been implicated
not only in motor function
but also in reward, perception,
learning, and memory.
All these functions require
selection processes,
and striatal synaptic
plasticity plays
a critical role in these selections.